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Abstract: To evaluate growth and enterotoxin production of Staphylococcus aureus in raw milk caciotta, an Italian soft cheese,
experimental cheesemaking trials were carried out with and without a commercial starter. Two different inocula of selected enterotoxinproducing S. aureus strains were tested: high (mean value 5.03 log CFU/mL of milk) and low (mean value 3.22 log CFU/mL of milk).
Uninoculated cheeses with milk containing 2.15 log CFU/mL mean value of coagulase-positive staphylococci were also examined. With
higher inocula coagulase-positive staphylococci counts reached 7.57 log CFU/g without starter and had significantly higher values after
the acidification phase than those with starter (below 6.5 log CFU/g). Using an enzyme immunoassay, enterotoxins were detected in
cheeses both without and with starter, but the latter showed significantly lower photometrical absorbance values than the former. In
low inoculum and uninoculated cheeses without starter, coagulase-positive staphylococci maximum values were between 5 and 6 log
CFU/g, without enterotoxin production. To enhance the safety of this cheese it is fundamental to strictly prevent coagulase-positive
staphylococci contamination and multiplication, particularly at the primary production level, and to correctly acidify the curd by starter
cultures, which can substantially limit total coagulase-positive staphylococci increase.
Key words: Caciotta cheese, enterotoxin production, experimental cheesemaking process, Staphylococcus aureus

1. Introduction
In Italy, dairy cattle breeding takes place both on large
farms, mainly in the northern regions where industrial
dairy plants are concentrated, and on small farms. On
the latter, which are located primarily in the central and
southern regions, raw milk is often utilised for direct onfarm production of traditional cheeses such as caciotta
cheeses, which are easily saleable on the local market.
The term caciotta refers to soft or semisoft cheeses
made with cow, ewe, or mixed milk; these are among the
most ancient Italian cheeses. The traditional production
is concentrated in Central Italy (mainly Tuscany, Latium,
Marches, and Umbria).
Today, caciotta production is spreading to all Italian
regions and is often made on an industrial scale with
pasteurised milk, reaching about 23,000,000 kg per year
according to the Italian Dairy Association (Assolatte)
(http://www.bancodibrescia.it/page/c/document_
librar y/get_file?uuid=fd918ae2-96b3-4d33-b1f1c8a4fc5ec73b&groupId=563303).
There are fundamentally 2 variants of caciotta; the cow
milk type, which has a white, sweet, and soft interior, and
the ewe or mixed milk type, with a stronger, more piquant
taste and a more yellowish paste consistency. The cheeses
* Correspondence: fpedones@vet.unipi.it
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are small-to-medium-sized, usually up to 2 kg in weight,
and the ripening period varies from 7–15 to about 45 days.
Moisture is between 40% and 45% depending on variants,
and salt content can reach a maximum 2.5% in more
ripened cheeses (1).
Among the microbiological hazards to be considered in
raw milk soft cheeses, staphylococcal enterotoxins, which
can be produced by about one-third of the coagulasepositive food origin Staphylococcus strains (2), are of major
concern. This is mainly due to the fact that Staphylococcus
aureus is one of the most important pathogens associated
with bovine mastitis (3) and is highly inclined to persist in
a herd in the form of subclinical infections, which have the
tendency to become chronic (4).
Thus, S. aureus is frequently related to food-borne
diseases from milk and milk product consumption; and
raw milk cheeses in particular have been repeatedly
involved in staphylococcal outbreaks (5–7). Studies in
different cheeses (8–15) have proven that both S. aureus
growth and enterotoxin production depend on many
factors, mainly cheesemaking characteristics and the use
of lactic acid starter cultures.
Since farmers in Central Italy often manufacture
caciotta cheeses with raw milk, the aim of this work was to
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evaluate the behaviour of S. aureus during the experimental
production of raw milk caciotta cheeses on a laboratory
scale, according to the traditional cheesemaking procedures
applied by small plants in Central Italy (Tuscany). Two sets
of experimental cheesemaking trials were carried out in
order to verify the growth and enterotoxin production of
S. aureus strains inoculated at high and low dosages and
explore the role of lactic acid starters in limiting them.
2. Materials and methods
2.1. Staphylococcus aureus strains
Two strains of Staphylococcus aureus (C21 and FB5)
belonging to the culture collection of the Laboratory of
Food Microbiology, Department of Veterinary Sciences,
University of Pisa, and isolated from raw milk and cheese,
respectively, were used. Strain identification was confirmed
both phenotypically by API STAPH (bioMérieux, Marcyl’Etoile, France) and genotypically at species level by
polymerase chain reaction using oligonucleotide primers
that amplified the thermonuclease encoding gene (nuc)
(16). The presence of genes encoding for production of
A, B, C, and D staphylococcal enterotoxins (SEs) was
tested in the examined strains genotypically (17). A, B,
C, and D SE production was also tested phenotypically
by reversed passive latex agglutination using SET-RPLA
Toxin Detection Kit (Oxoid, Basingstoke, Great Britain). S.
aureus ATCC 25923 and 6538 strains were used as controls.
2.2. Cheesemaking trials
Raw cow milk was obtained from the experimental farm
of the Interdepartmental Centre for Agro-Environmental
Research, Enrico Avanzi (University of Pisa). Experimental
mini-cheeses of about 150 g were manufactured in the
laboratory following the cheesemaking procedure used
for traditional caciotta cheese produced in a Tuscan dairy
factory with the usual starter cultures (Streptococcus
thermophilus) and rennet. In a first phase (phase 1), 4
experimental groups of cheeses were defined: with S.
aureus-inoculated milk and without a lactic acid starter
(SA+ st–), with S. aureus-inoculated milk and with a starter
(SA+ st+), without S. aureus inoculum and without a
starter (SA– st–), and without S. aureus inoculum and with
a starter (SA– st+). For each group, 3 independent batches
were prepared for a total of 12 batches. Each batch was
prepared in duplicate using 5 + 5 L of the same milk (and
the same S. aureus-inoculated milk for SA+ groups). In a
second set of trials (phase 2), 2 independent batches (not
duplicated) were prepared for each of the 4 groups (2SA+
st–, 2SA+ st+, 2SA– st–, and 2SA– st+) using a lower S.
aureus inoculum.
In the trials with S. aureus-adjunct cultures the
inoculum was prepared as follows: strains were previously
transferred twice on brain–heart infusion broth (Oxoid)
and incubated at 37 °C. Then, a 1% inoculum of both strains

in the same medium was made, and bacterial cells were
pelleted, washed twice, and prepared by dilution in sterile,
reconstituted skim milk (Oxoid) to obtain a staphylococcal
count in the range 106–108 and 105–106 CFU/mL in phases
1 and 2, respectively. Inoculated milk was then added
(1% v/v) to raw milk in order to obtain a final amount
of inoculated S. aureus in the range 104–106 and 103–104
CFU/mL, respectively, for phases 1 and 2. In all trials
milk was warmed to 38 ± 2 °C. For SA+ st+ and SA– st+
cheeses, a commercial thermophilic starter (Streptococcus
thermophilus, MIX CR 02, Uniferm, Saviano, Napoli,
Italy) was added. The starter contains approximately
10 log CFU/g of thermophilic streptococci. Following
the supplier’s instructions, a count of approximately 6
log CFU of thermophilic streptococci/mL of milk was
obtained. For the coagulation 0.05 g/L of a commercial
calf powder rennet (Caglificio Clerici, Cadorago, Como,
Italy; chymosin 96%, pepsin 4%) were used. The curd
was cut in 2 phases into hazelnut-sized grains, extracted
after about 1 h from the rennet addition, and placed into
plastic moulds. Acidification and draining were completed
into a covered plastic box where the cheese temperature
was maintained between 33 °C and 37 °C with hot water
and steam (steaming phase). For the SA+ st+ and SA– st+
groups the steaming phase lasted until a pH value of at
least 5.3 was reached, an index of good acidification. For
the SA+ st– and SA– st– groups the steaming phase lasted
3 h. This is the usual length of the steaming phase in the
traditional cheesemaking process and the average time
necessary to obtain a pH value of 5.3 using starter. Cheeses
were then dry salted and stored at 7 ± 1 °C for 14 days.
2.3. Milk and cheese samples
Samples of uninoculated and inoculated milk, samples
of cheese before the steaming phase (BS) and after the
steaming phase (AS), and at 24 h (24H) and 14 days
(14D) after manufacture were immediately submitted
to physicochemical and microbiological analyses. A
portion of the same samples was frozen at – 20 °C for SE
determination.
2.4. Physicochemical analyses
The pH was measured in each milk sample from phases 1
and 2 and in each cheese sample from phase 1. For phase
2, the pH was measured only in cheese samples after the
steaming phase (AS). The pH values were determined
by using a GLP 21 pH meter (Crison Instruments S.A.,
Barcelona, Spain) with a penetration electrode and an
automatic temperature compensator.
Aw values were registered in four 24H-cheeses of phase
2, one for each group, using a Rotronic PBI AWYD device
(PBI International, Milano, Italy).
2.5. Microbiological analyses
Total bacterial count was determined on raw, uninoculated
milk on plate count agar (Oxoid) at 30 °C for 72 h.
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Coagulase-positive staphylococci (CPS) were enumerated
applying the UNI EN ISO Standard 6888-1:2000 (18) on
uninoculated and inoculated milk and on cheese samples.
2.6. Enterotoxin determination
For the combined detection of SEs in cheese samples
the sandwich enzyme immunoassay RIDASCREEN SET
Total (R-Biopharm AG, Darmstadt, Germany) was used.
The results were evaluated photometrically by measuring
the absorbance at 450 nm against a reference filter of 630
± 10 nm with a Multiskan FC v. 1.00.79 microwell plate
photometer (Thermo Fisher Scientific, Waltham MA,
USA). In this method the cut-off value for evaluation of
results as positive or negative is calculated by adding 0.15
to the optical density (OD) value registered for the negative
control. OD values higher than the cut-off are considered
positive. For phase 1, all cheese samples were tested. For
each batch and technological stage (BS, AS, 24H, and
14D) a pool of the 2 corresponding cheeses made in
duplicate was used. For phase 2, only 24H-cheese samples
of 2SA+ st+ and 2SA+ st– groups were tested. OD values
of RIDASCREEN-positive samples of phase 1, beginning
from AS phase, were used as relative absorbance values to
make a comparison between SA+ st– and SA+ st+ results.
According to the supplier’s instructions, OD values higher
than 2.5 are considered positive; however, there is no
linearity between OD values and enterotoxin amounts.
Thus, a fixed OD value of 2.5 was assigned in these cases.
In addition, the production of each tested SE was
verified on SA+ st– 24H-cheese samples by SET RPLA
Toxin Detection Kit.
2.7. Statistical analysis
Statistical analyses were performed using R v. 2.15 software
(R Foundation for Statistical Computing, Vienna, Austria).
Data from phase 1 and 2 milk and cheeses were subjected

to the 1-way ANOVA test and Tukey’s HSD test for posthoc comparisons. The experimental group was used as the
factor to determine the effect of starter cultures on pH values
and CPS counts for phase 1 and on CPS counts for phase
2 for each stage of the cheesemaking process. Significance
of differences was determined at the 0.01 probability level.
Results from microbial counts were previously converted
into log CFU/g. As to the SE production data, the differences
in OD values were evaluated with the 2-way ANOVA test
and Tukey’s HSD test for post-hoc comparisons using the
experimental group and the cheesemaking stage as factors;
values were considered statistically different if associated
with a P value lower than 0.05.
3. Results
3.1. Physicochemical measurements
The milk used for the trials in phases 1 and 2 had a pH of
about 6.7, which is the normal value for cow milk.
First phase: Mean values of pH evolution in the 4
experimental groups are reported in the Figure. Significantly
different values were obtained beginning from AS stage,
both between SA+ st– and SA+ st+ and between SA– st–
and SA– st+.
Second phase: Mean pH values measured in AS samples
were 6.54 ± 0.16 for 2SA+ st–, 5.32 ± 0.02 for 2SA+ st+, 6.51
± 0.13 for SA– st–, and 5.31 ± 0.03 for SA– st+.
The mean Aw value in 24H samples was 0.977 ± 0.010.
This rather low value is probably due to the very small size
of the experimental cheeses which created a high surface/
volume ratio.
3.2. Microbiological analyses and enterotoxin production
On the basis of the API STAPH results, C21 and FB5
strains were identified as Staphylococcus aureus with an
identification percentage (%ID, given by the supplier’s

7.00

pH value

6.50
SA+ st–
SA+ st+
SA– st–
SA– st+

6.00
5.50
5.00
4.50

BS

AS

24H

Cheesemaking phase

14D

Figure. Evolution of pH values of phase 1 cheeses examined at the different cheesemaking
stages. SA+: cheeses with experimental inoculum of Staphylococcus aureus; SA–: cheeses
without experimental inoculum of Staphylococcus aureus; st+: cheeses with lactic acid
starter; st–: cheeses without lactic acid starter. BS: cheeses before the steaming phase;
AS: cheeses after the steaming phase; 24H: cheeses 24 h after manufacture; 14D: cheeses
14 days after manufacture.
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SEs, proving that the 2 experimental S. aureus strains were
able to grow sufficiently without reciprocal inhibition.
Second phase: In Table 3 the results (CPS counts) of
trials carried out with a low S. aureus inoculum are shown.
The highest mean value of CPS was 5.37 log CFU/g in
2SA+ st– cheeses. SEs were never detected in the examined
samples.

software) higher than 97%, as confirmed by genotypical
analyses, which revealed the presence of the nuc gene for
both strains. PCR revealed the presence of the C toxin gene
for C21 and the A and D toxin genes for the FB5 strain.
SET-RPLA Toxin Detection Kit results confirmed the
production of these toxins.
Raw milk used for the cheesemaking trials of phases 1
and 2 constantly showed total bacterial counts within the
legal limit of 5 log CFU/mL (4.66 ± 0.32 log CFU/mL),
and the CPS mean value (2.15 ± 0.17 log CFU/mL) was
acceptable with respect to Italian microbiological criteria
for raw milk intended for direct human consumption (500
CFU/mL) (19).
First phase: Results regarding the behaviour of CPS
during the cheesemaking process in phase 1 are shown
in Table 1. The statistical comparison between cheese
samples with and without starter showed that CPS counts
were significantly different in all cheesemaking phases
beginning from AS, both for SA+ and SA– cheeses. As
expected, significant differences were consistently found
between the SA+ and SA– groups, beginning from the
milk.
SEs were detected in all SA+ st– and SA+ st+ cheese
samples with the exception of BS samples, among which
only 1 SA+ st– sample deriving from the batch with the
strongest inoculum of S. aureus was positive. SA– samples
never revealed the presence of SEs. Total OD mean values
of positive AS, 24H, and 14D samples were 2.212 ± 0.603
and 0.591 ± 0.305 for SA+ st– and SA+ st+, respectively.
As shown in Table 2, OD mean values of positive SA+
st+ samples were significantly lower than those of SA+
st– samples. Indeed, the 2-way ANOVA test showed the
statistical significance of both factors (experimental group
and cheesemaking stage), and post-hoc comparisons
revealed that the decrease in OD values observed in 14D
samples was statistically significant.
With regard to the type of SEs found in cheeses, results
demonstrated the simultaneous production of A, C, and D

4. Discussion
Among the different categories of cheeses, soft cheeses such
as Italian caciotta represent a very suitable environment for
the growth of CPS and, consequently, for SE production
due to their high Aw values and their technological cycle,
which maintains temperature values close to the optimum
range for mesophilic bacteria for some hours in the
early stages of the cheesemaking process. In these cases,
especially if raw milk is used, the acidification process is of
the utmost importance.
In our study commercial thermophilic starter gave rise
to rapid acidification and active proliferation of lactic acid
bacteria, both in SA+ and SA– caciotta cheeses in which
pH values gradually fell as far as 5.3 during cheesemaking.
As expected, the most effective cheesemaking period was
the steaming phase when the cheeses remained at the best
temperature range for acidifying action; thus, the highest
pH decrease was noted between BS and AS samples. As to
the trials carried out without a lactic acid starter, pH values
decreased only slightly because of the very weak acidifying
activity of autochthonous lactic acid bacteria from both
the milk and the environment. The low-temperature
ripening did not permit a valid multiplication of lactic
acid microorganisms, and pH remained substantially
unchanged, approximately 5.3 when a starter was used and
over 6 without a starter.
In SA+ cheeses with a starter CPS (maximum mean
value: 6.43 log CFU/g) showed an increase between 0.5
and 1 log CFU/g during the steaming phase, whereas
in SA+ cheeses produced without starter (maximum

Table 1. Coagulase-positive staphylococci counts (CPS) (mean ± standard deviation, log CFU/mL or g) in phase 1
cheeses of different experimental groups examined at the different cheesemaking stages.
M

BS

AS

24H

14D

SA+ st–

4.88 ± 0.70

a

SA+ st+

5.18 ± 0.56

a

SA– st–

2.20 ± 0.17b

3.04 ± 0.17b

5.56 ± 0.14c

5.65 ± 0.12c

5.24 ± 0.16c

SA– st+

2.10 ± 0.17

2.62 ± 0.03

3.15 ± 0.22

3.39 ± 0.26

3.46 ± 0.17d

b

5.59 ± 0.66

7.27 ± 0.34

7.57 ± 0.13

7.51 ± 0.09a

5.60 ± 0.44

6.27 ± 0.31

b

6.43 ± 0.45

5.92 ± 0.38b

a
a

b

a
b

d

a

d

SA+: cheeses with experimental inoculum of Staphylococcus aureus; SA–: cheeses without experimental inoculum of
S. aureus; st+: cheeses with lactic acid starter; st–: cheeses without lactic acid starter. M: CPS count in milk; BS: CPS
count before the steaming phase; AS: CPS count after the steaming phase; 24H: CPS count 24 h after manufacture;
14D: CPS count 14 days after manufacture. Different letters in the same column indicate significant differences (P
< 0.01).
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Table 2. Optical density (OD) values (mean ± standard deviation)
of phase 1 cheeses of the SA+ st– and SA+ st+ groups examined
at the different cheesemaking stages.
SA+ st–

of both SA– st– and SA– st+ never revealed the presence
of SEs, in contrast with SA+ st– and SA+ st+, which had a
strong S. aureus initial inoculum.
In all groups total CPS increases revealed very poor
or no multiplying action in the manufacturing stages
after the steaming phase, and in the case of SA+ st+ they
even showed a decrease during the ripening period. This
decrease, which should be further verified, could be due to
the lower vitality of inoculated S. aureus strains (C21 and
FB5) in the presence of the starter cultures; in 2SA+ st+ the
wild CPS, not wiped out by a great number of inoculated S.
aureus strains, could have limited the decrease. A similar
decrease between 24H and 14D samples, corresponding
to a slight pH decrease, was also noted in SA– st– group,
where autochthonous lactic acid bacteria probably played
a role.
In absence of the thermal treatment of milk, as in
the examined cheeses, even low initial levels of S. aureus
can lead to the production of SEs. In particular, counts
greater than 103 CFU/mL in milk can reach unsafe levels
(7) due to their multiplication potential. In the case of the
S. aureus values tested in phase 2 milk (maximum mean
value 3.34 log CFU/mL), it was indeed possible to reach
counts of about 105 CFU/g during the cheesemaking
process with increases analogous to those of phase 1, but
this did not lead to SE production. In fact, based on the
current knowledge (21) enterotoxin detection in cheeses
is usually correlated with higher S. aureus counts (about
106–107 CFU/g).
Considering the SE positive samples found in phase
1 SA+ cheeses, even if the RIDASCREEN method gives
only qualitative results in absence of a titration curve,
it is noteworthy that the OD mean values of SA+ st–
AS, 24H, and 14D samples were significantly higher
than those of SA+ st+. This fact, together with evidence
that the staphylococcal counts of SA+ st+ cheeses were

SA+ st+

AS

2.500 ± 0.000a

0.866 ± 0.043c

24H

a

2.500 ± 0.000

0.609 ± 0.326c

14D

1.637 ± 0.841b

0.298 ± 0.146d

SA+: cheeses with experimental inoculum of Staphylococcus
aureus; st+: cheeses with lactic acid starter; st–: cheeses without
lactic acid starter. AS: OD values after the steaming phase; 24H:
OD values 24 h after manufacture; 14D: OD values 14 days after
manufacture. Different letters in the same row and column
indicate significant differences (P < 0.05).

mean CPS value: 7.57 log CFU/g) the corresponding
increase was between 1.5 and 2 log CFU/g. Similarly, in
SA– cheeses with starter (maximum mean value: 3.46 log
CFU/g) the acidification determined by lactic acid bacteria
gave rise to a strong limitation in the autochthonous CPS
in the same phase. Indeed, CPS easily multiplied in SA–
cheeses without starter where they reached (even without
SE production) the EU CPS level considered a risk with
respect to staphylococcal food poisoning (105 CFU/g) (20).
This finding is not uncommon in Italian traditional raw
milk soft cheeses produced without starter (http://www.
agricoltura.regione.lombardia.it/shared/ccurl/143/792/
AL_20090412_3654_quaderno_78_AGR_MS.pdf ).
Considering the absence of starter in both products, the
CPS increase in SA– st–, which was higher than in SA+ st–,
could be due to CPS counts close to the maximum limits
of the bacterial growth curve in the latter, after which a
slowing down begins and/or greater multiplying impetus
in the autochthonous strains in comparison with the
inoculated ones (see also phase 2). Nevertheless, samples

Table 3. Coagulase-positive staphylococci counts (CPS) (mean ± standard deviation, log CFU/mL or g) in phase 2
cheeses of different experimental groups examined at the different cheesemaking stages.
M

BS

AS

24H

14D

2SA+ st–

3.09 ± 0.12 a

3.88 ± 0.31 a

5.18 ± 0.13 a

5.37 ± 0.10 a

5.30 ± 0.39 a

2SA+ st+

3.34 ± 0.19 a

3.95 ± 0.10 a

4.75 ± 0.35 a

5.02 ± 0.11 a

4.91 ± 0.16 a

2SA– st–

1.94 ± 0.34 b

2.87 ± 0.12 a

4.85 ± 0.14 a

4.99 ± 0.19 a

4.94 ± 0.13 a

2SA– st+

2.17 ± 0.13 b

2.53 ± 0.39 a

3.08 ± 0.25 b

3.30 ± 0.09 b

3.39 ± 0.16 b

2SA+: cheeses with experimental inoculum of Staphylococcus aureus; 2SA–: cheeses without experimental inoculum
of S. aureus; st+: cheeses with lactic acid starter; st–: cheeses without lactic acid starter. M: CPS count in milk;
BS: CPS count before the steaming phase; AS: CPS count after the steaming phase; 24H: CPS count 24 h after
manufacture; 14D: CPS count 14 days after manufacture. Different letters in the same column indicate significant
differences (P < 0.01).
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significantly lower than those of the corresponding SA+
st– cheeses, confirms that starter cultures were effective
in limiting staphylococcal growth and the subsequent
SE production, even in the presence of very high initial
S. aureus contamination. The inhibitory effect of starter
cultures is well known and related not only to the pH
decrease through lactic acid production, but also to
competition mechanisms and the release of substances
such as hydrogen peroxide and bacteriocins (22–24).
Moreover, lactic acid bacteria can also exert their action
on SEs. A decreasing action of some lactic acid bacteria
on SEA levels (Lactobacillus, Streptococcus thermophilus,
and Pediococcus) was found when partially purified SEA
was added to microbiological media inoculated with
these microorganisms. This reduction was measured by a
serological method and was not simply due to decreases in
pH, since uninoculated SEA-containing media, acidified
up to pH 3 with lactic acid, had no effect (25). Such an
action, probably causing modifications in the antigenic
profile of SEs with the consequent loss of immunological
reactivity, could have had a role in determining the decrease
in OD values shown by 14D samples of SA+ st+ (starter
lactic acid bacteria) and SA+ st– (autochthonous lactic
acid bacteria). Some studies (26,27) have demonstrated
that the loss of C- and N-terminal amino acids causes loss
of conformation, superantigenic, and serological activity
in SEs. Lactic acid bacteria could act in such a way via their
proteolytic properties. Weight loss in cheeses during the
ripening could also have contributed to the decrease. Since
these aspects have been very poorly explored, our findings
must be adequately supported by additional data.
In spite of their merits, raw milk cheeses are still
traditionally manufactured in the absence of lactic acid
starter cultures on many small dairy farms; in other cases
commercial starters are misused and fail to produce

effective acidification. In these situations, the greatest
attention should be paid to maintaining the CPS values in
milk as low as possible, to avoid unnecessary prolongation
of manufacturing and optimise the production process at
the lowest temperatures suitable for typical cheesemaking.
Since these precautions cannot be sufficient to avoid SE
poisoning, there is a need for the widest diffusion of basic
information with the aim of sharing with artisanal raw
milk soft cheese makers the benefits of correctly using
lactic acid starters. In fact, these are cheap and easy tools
for enhancing the safety of cheeses that generally do not
cause undesirable changes in typical traits; rather, they
can improve flavour and lead to higher standardisation.
When the use of a commercial starter is not possible,
natural autochthonous milk starter cultures could be
substituted. In both cases, the starter acidifying action
has to be properly managed by applying adequate timetemperature parameters and by carefully monitoring pH
evolution.
Obviously, the correct employment of starter cultures
is not sufficient to ensure food safety if CPS counts are
not adequately low in the milk (within 3.5 log CFU/
mL, in our experience) and good hygiene practices are
not fully applied during each phase of milk and cheese
production. In these cases, milk pasteurisation is strongly
recommended.
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